Presence of apolipoprotein E immunoreactivity in degenerating neurones of mice is dependent on the severity of kainic acid-induced lesion
暂无分享,去创建一个
E. R. Kloet | D. Jaarsma | E. Haasdijk | M. Mulder | E. R. Kloet | E.Ron de Kloet | J. Grootendorst | Jeannette Grootendorst
[1] S. Strickland,et al. Neuronal Death and Blood–Brain Barrier Breakdown after Excitotoxic Injury Are Independent Processes , 1999, The Journal of Neuroscience.
[2] G. Rondouin,et al. Hippocampal alterations of apolipoprotein E and D mRNA levels in vivo and in vitro following kainate excitotoxicity , 1999, Epilepsy Research.
[3] R. Pearlstein,et al. Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouse. , 1999, Stroke.
[4] R. Demattos,et al. A Test of the Cytosolic Apolipoprotein E Hypothesis Fails to Detect the Escape of Apolipoprotein E from the Endocytic Pathway into the Cytosol and Shows that Direct Expression of Apolipoprotein E in the Cytosol is Cytotoxic , 1999, The Journal of Neuroscience.
[5] D. Graham,et al. Influence of apolipoprotein E genotype on neuronal damage and apoE immunoreactivity in human hippocampus following global ischemia. , 1999, Journal of neuropathology and experimental neurology.
[6] J. Gilbert,et al. Specific regional transcription of apolipoprotein E in human brain neurons. , 1999, The American journal of pathology.
[7] P. Froom,et al. Apolipoprotein E-ε4 genotype predicts a poor outcome in survivors of traumatic brain injury , 1999, Neurology.
[8] B. Hyman,et al. Dissociation of apolipoprotein and apolipoprotein receptor response to lesion in the rat brain: An in situ hybridization study , 1998, Neuroscience.
[9] A. Fagan,et al. Evidence for Normal Aging of the Septo-Hippocampal Cholinergic System in apoE (−/−) Mice but Impaired Clearance of Axonal Degeneration Products Following Injury , 1998, Experimental Neurology.
[10] A. Roses,et al. Apolipoprotein E and the CNS Response to Injury , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] J. Victoroff,et al. Increased Apolipoprotein E mRNA in the Hippocampus in Alzheimer Disease and in Rats after Entorhinal Cortex Lesioning , 1998, Experimental Neurology.
[12] T. McNeill,et al. Differential Regulation of Astrocytic mRNAs in the Rat Striatum after Lesions of the Cortex or Substantia Nigra , 1998, Experimental Neurology.
[13] A. Roses. Apolipoprotein E, a Gene with Complex Biological Interactions in the Aging Brain , 1997, Neurobiology of Disease.
[14] T. Wisniewski,et al. Biology of Aβ Amyloid in Alzheimer's Disease , 1997, Neurobiology of Disease.
[15] R. T. Carroll,et al. Cerebral lipid deposition in aged apolipoprotein-E-deficient mice. , 1997, The American journal of pathology.
[16] G. Murray,et al. Association of apolipoprotein E polymorphism with outcome after head injury , 1997, The Lancet.
[17] D. Michaelson,et al. Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury , 1997, Neuroscience.
[18] J. Nicoll,et al. Marked alterations in the cellular localisation and levels of apolipoprotein E following acute subdural haematoma in rat , 1997, Brain Research.
[19] C. Kawas,et al. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization. , 1997, The Journal of clinical investigation.
[20] A. Roses,et al. Apolipoprotein E-Deficient Mice Have Increased Susceptibility To Focal Cerebral Ischemia , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[21] W. Ong,et al. Differential expression of apolipoprotein D and apolipoprotein E in the kainic acid-lesioned rat hippocampus , 1997, Neuroscience.
[22] M. Gearing,et al. Astrocyte‐Apolipoprotein E Associations in Senile Plaques in Alzheimer Disease and Vascular Lesions: A Regional Immunohistochemical Study , 1997, Journal of neuropathology and experimental neurology.
[23] L. Havekes,et al. Severe learning deficits in apolipoprotein E-knockout mice in a water maze task , 1997, Brain Research.
[24] A. Hofman,et al. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. , 1997, JAMA.
[25] T. Morgan,et al. Astrocytes and Microglia Respond to Estrogen with Increased apoE mRNAin Vivoandin Vitro , 1997, Experimental Neurology.
[26] E. Masliah,et al. ALTERATIONS IN APOLIPOPROTEIN E EXPRESSION DURING AGING AND NEURODEGENERATION , 1996, Progress in Neurobiology.
[27] Jonathan D. Smith,et al. Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides , 1996, Nature Genetics.
[28] K. Horsburgh,et al. Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the rat , 1996, Neuropathology and applied neurobiology.
[29] Bradley T. Hyman,et al. Apolipoprotein E ε4 Is Associated With the Presence and Earlier Onset of Hemorrhage in Cerebral Amyloid Angiopathy , 1996 .
[30] Grootendorst,et al. Dexamethasone Does Not Prevent Seven-Day ADX-Induced Apoptosis in the Dentate Gyrus of the Rat Hippocampus. , 1996, Stress.
[31] G. Getz,et al. Neurons of the Human Frontal Cortex Display Apolipoprotein E Immunoreactivity: Implications for Alzheimer's Disease , 1996, Journal of neuropathology and experimental neurology.
[32] L. Donehower,et al. Loss of the p53 tumor suppressor gene protects neurons from kainate- induced cell death , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[33] R. Mahley,et al. Apolipoprotein E. Structure, Function, and Possible Roles in Alzheimer's Disease a , 1996, Annals of the New York Academy of Sciences.
[34] J. Gilbert,et al. Morphological, Biochemical, and Genetic Support for an Apolipoprotein E Effect on Microtubular Metabolism a , 1996, Annals of the New York Academy of Sciences.
[35] A. Roses,et al. Neurodegeneration in the Central Nervous System of apoE-Deficient Mice , 1995, Experimental Neurology.
[36] R. Mahley,et al. Stable Expression and Secretion of Apolipoproteins E3 and E4 in Mouse Neuroblastoma Cells Produces Differential Effects on Neurite Outgrowth (*) , 1995, The Journal of Biological Chemistry.
[37] D. Holtzman,et al. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[38] E. Hall,et al. Increased Amyloid Protein Precursor and Apolipoprotein E Immunoreactivity in the Selectively Vulnerable Hippocampus Following Transient Forebrain Ischemia in Gerbils , 1995, Experimental Neurology.
[39] K. Wisniewski,et al. Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down's syndrome brain , 1995, Brain Research.
[40] H. Wiśniewski,et al. Complete cerebral ischemia with short-term survival in rat induced by cardiac arrest. II. Extracellular and intracellular accumulation of apolipoproteins E and J in the brain , 1995, Brain Research.
[41] J. Poirier. Apolipoprotein E in animal models of CNS injury and in alzheimer's disease , 1994, Trends in Neurosciences.
[42] J. de Olmos,et al. Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia, and physical trauma. , 1994, Neurotoxicology and teratology.
[43] B. Wieringa,et al. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. , 1994, Atherosclerosis.
[44] A. Roses,et al. Apolipoprotein E Is Localized to the Cytoplasm of Human Cortical Neurons: A Light and Electron Microscopic Study , 1994, Journal of neuropathology and experimental neurology.
[45] M. Pericak-Vance,et al. Apolipoprotein E Is Present in Hippocampal Neurons without Neurofibrillary Tangles in Alzheimer's Disease and in Age-Matched Controls , 1994, Experimental Neurology.
[46] V. Perry,et al. Mitosis and apoptosis of microgliain vivo induced by an anti-CR3 antibody which crosses the blood-brain barrier , 1993, Neuroscience.
[47] M. Pericak-Vance,et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[48] B. Hyman,et al. Neuroanatomical connections and specific regional vulnerability in Alzheimer's disease , 1993, Neurobiology of Aging.
[49] K. Sako,et al. Experimental complex partial seizures induced by a microinjection of kainic acid into limbic structures , 1992, Progress in Neurobiology.
[50] J. Korf,et al. Time course and distribution of neuronal degeneration in the dentate gyrus of rat after adrenalectomy: A silver impregnation study , 1992, Hippocampus.
[51] V. Perry,et al. The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration , 1991, Neuroscience.
[52] A. Haase,et al. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes , 1991, Journal of virology.
[53] C. Finch,et al. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. , 1991, Brain research. Molecular brain research.
[54] L. Notterpek,et al. Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I. , 1990, The Journal of biological chemistry.
[55] H. Rosen,et al. The role of the type 3 complement receptor in the induced recruitment of myelomonocytic cells to inflammatory sites in the mouse. , 1990, American journal of respiratory cell and molecular biology.
[56] H. Shimano,et al. Plasma apolipoproteins in patients with multi-infarct dementia. , 1989, Atherosclerosis.
[57] E. Shooter,et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. , 1989, The Journal of clinical investigation.
[58] L. Swanson,et al. Localization of mRNA for low density lipoprotein receptor and a cholesterol synthetic enzyme in rabbit nervous system by in situ hybridization. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[59] R. Mahley,et al. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.
[60] G. Stoll,et al. Macrophages in the peripheral nervous system and astroglia in the central nervous system of rat commonly express apolipoprotein E during development but differ in their response to injury , 1986, Neuroscience Letters.
[61] E. Shooter,et al. Expression of apolipoprotein E during nerve degeneration and regeneration. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[62] J. Freeman,et al. Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[63] J. Taylor,et al. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. , 1985, The Journal of clinical investigation.
[64] O. Hornykiewicz,et al. Kainic acid-induced seizures: Dose-relationship of behavioural neurochemical and histopathological changes , 1985, Brain Research.
[65] E. Shooter,et al. A specific 37,000-dalton protein that accumulates in regenerating but not in nonregenerating mammalian nerves. , 1985, Science.
[66] S. Kish,et al. Kainic acid induced seizures: Neurochemical and histopathological changes , 1983, Neuroscience.
[67] A. Roses,et al. Apolipoprotein E and Alzheimer's disease. , 1996, Annual review of neuroscience.
[68] O. Steward,et al. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[69] L. Heimer,et al. Silver staining as a tool for neurotoxic assessment. , 1993, NIDA research monograph.
[70] J. Nadler,et al. [25] Use of excitatory amino acids to make axon-sparing lesions of hypothalamus , 1983 .